Cyren (CYRNQ) 10-Q 16 Nov 20 2020 Q3 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	9 Months Ended
	Sep. 30, 2020	Oct. 31, 2020
Document Information Line Items
Entity Registrant Name	CYREN Ltd.
Document Type	10-Q
Current Fiscal Year End Date	--12-31
Entity Common Stock, Shares Outstanding		60,919,503
Amendment Flag	false
Entity Central Index Key	0001084577
Entity Current Reporting Status	Yes
Entity Filer Category	Non-accelerated Filer
Document Period End Date	Sep. 30, 2020
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	Q3
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity File Number	000-26495
Entity Incorporation, State or Country Code	L3
Entity Interactive Data Current	Yes

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019
CURRENT ASSETS:
Cash and cash equivalents	$ 12,894	$ 11,551
Trade receivables (net of allowances for doubtful accounts of $207 and $129, respectively)	2,348	2,187
Deferred commissions	1,004	948
Prepaid expenses and other receivables	1,284	819
Total current assets	17,530	15,505
LONG-TERM ASSETS:
Long-term deferred commissions	1,243	1,580
Long-term lease deposits	863	767
Operating lease right-of-use assets	11,191	8,695
Severance pay fund	646	659
Property and equipment, net	4,410	4,410
Intangible assets, net	8,093	8,966
Goodwill	20,818	20,246
Total long-term assets	47,264	45,323
Total assets	64,794	60,828
CURRENT LIABILITIES:
Trade payables	1,103	1,184
Employees and payroll accruals	3,676	3,427
Accrued expenses and other liabilities ($181 and $40 attributable to related parties, respectively)	1,160	1,145
Operating lease liabilities	1,889	1,946
Deferred revenues	9,272	7,208
Total current liabilities	17,100	14,910
LONG-TERM LIABILITIES:
Deferred revenues	1,064	1,956
Convertible notes (related party)	10,000	10,000
Convertible Debentures ($233 attributable to related parties)	9,344
Long-term operating lease liabilities	9,678	7,174
Deferred tax liability	646	796
Accrued severance pay	762	811
Other liabilities	653	470
Total long-term liabilities	32,147	21,207
COMMITMENTS AND CONTINGENCIES
SHAREHOLDERS’ EQUITY:
Ordinary shares nominal value ILS 0.15 par value - Authorized: 110,000,000 shares at September 30, 2020 (Unaudited) and December 31, 2019; Issued and Outstanding: 60,919,503 and 59,372,173 shares at September 30, 2020 (Unaudited) and December 31, 2019, respectively	2,376	2,309
Additional paid-in capital	258,177	255,741
Accumulated other comprehensive loss	(1,420)	(2,010)
Accumulated deficit	(243,586)	(231,329)
Total shareholders’ equity	15,547	24,711
Total liabilities and shareholders’ equity	$ 64,794	$ 60,828

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parentheticals) $ in Thousands	Sep. 30, 2020USD ($)shares	Sep. 30, 2020₪ / shares	Dec. 31, 2019USD ($)shares	Dec. 31, 2019₪ / shares
Statement of Financial Position [Abstract]
Allowances for doubtful accounts (in Dollars) | $	$ 207		$ 129
Accrued expenses and other liabilities attributable to related parties (in Dollars) | $	181		$ 40
Convertible debentures attributable to related parties (in Dollars) | $	$ 233
Ordinary shares, par value (in New Shekels per share) | ₪ / shares		₪ 0.15		₪ 0.15
Ordinary shares, authorized | shares	110,000,000		110,000,000
Ordinary shares, issued | shares	60,919,503		59,372,173
Ordinary shares, outstanding | shares	60,919,503		59,372,173

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (Unaudited) - USD ($) $ in Thousands		3 Months Ended		9 Months Ended
		Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Income Statement [Abstract]
Revenues		$ 9,114	$ 9,496	$ 27,944	$ 28,862
Cost of revenues		3,792	3,712	11,168	11,501
Gross profit		5,322	5,784	16,776	17,361
Operating expenses:
Research and development, net		4,769	3,516	12,264	11,990
Sales and marketing		2,942	3,027	9,123	10,473
General and administrative		2,302	2,484	6,992	7,314
Total operating expenses		10,013	9,027	28,379	29,777
Operating loss		(4,691)	(3,243)	(11,603)	(12,416)
Other income, net		1	(3)	9	262
Financial expenses, net	[1]	(235)	(321)	(757)	(642)
Loss before taxes on income		(4,925)	(3,567)	(12,351)	(12,796)
Tax benefit		33	37	94	117
Loss		$ (4,892)	$ (3,530)	$ (12,257)	$ (12,679)
Basic and diluted loss per share (in Dollars per share)		$ (0.08)	$ (0.06)	$ (0.20)	$ (0.23)
Weighted-average number of shares used in computing basic and diluted loss per share (in Shares)		60,580	54,554	60,103	54,389
[1]	Transactions with related parties are included in the line item above (refer to Footnote 8, Related Parties, of the Notes to Consolidated Financial Statements for additional information).

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Loss (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Statement of Comprehensive Income [Abstract]
Loss	$ (4,892)	$ (3,530)	$ (12,257)	$ (12,679)
Other comprehensive income (loss):
Foreign currency translation adjustments	591	(622)	590	(718)
Comprehensive loss	$ (4,301)	$ (4,152)	$ (11,667)	$ (13,397)

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Changes in Shareholders' Equity (Unaudited) - USD ($) $ in Thousands	Number of outstanding ordinary shares	Additional paid-in capital	Treasury shares	Accumulated other comprehensive income (loss)	[1]	Accumulated deficit	Total
Balance at Dec. 31, 2018	$ 2,097	$ 245,570	$ (998)	$ (1,666)		$ (213,143)	$ 31,860
Balance (in Shares) at Dec. 31, 2018	54,057,208
Issuance of treasury shares upon exercise of options and vesting of restricted share units		(403)	998			(168)	427
Issuance of treasury shares upon exercise of options and vesting of restricted share units (in Shares)	348,673
Issuance of ordinary shares upon exercise of options and vesting	$ 1	315					316
Issuance of ordinary shares upon exercise of options and vesting (in Shares)	241,976
Payment of interest in shares	$ 1	70					71
Payment of interest in shares (in Shares)	35,950
Stock-based compensation related to employees, directors and consultants		1,002					1,002
Other comprehensive loss				(718)			(718)
Loss						(12,679)	(12,679)
Balance at Sep. 30, 2019	$ 2,099	246,554		(2,384)		(225,990)	20,279
Balance (in Shares) at Sep. 30, 2019	54,683,807
Balance at Jun. 30, 2019	$ 2,098	245,905		(1,762)		(222,460)	23,781
Balance (in Shares) at Jun. 30, 2019	54,501,307
Issuance of treasury shares upon exercise of options and vesting of restricted share units
Issuance of treasury shares upon exercise of options and vesting of restricted share units (in Shares)
Issuance of ordinary shares upon exercise of options and vesting	$ 1	230					231
Issuance of ordinary shares upon exercise of options and vesting (in Shares)	182,500
Payment of interest in shares
Payment of interest in shares (in Shares)
Stock-based compensation related to employees, directors and consultants		419					419
Stock-based compensation related to employees, directors and consultants (in Shares)
Other comprehensive loss				(622)			(622)
Loss						(3,530)	(3,530)
Balance at Sep. 30, 2019	$ 2,099	246,554		(2,384)		(225,990)	20,279
Balance (in Shares) at Sep. 30, 2019	54,683,807
Balance at Dec. 31, 2019	$ 2,309	255,741		(2,010)		(231,329)	24,711
Balance (in Shares) at Dec. 31, 2019	59,372,173
Restricted stock units vested	$ 38	(38)
Restricted stock units vested (in Shares)	856,132
Payment of interest in shares	$ 17	414					431
Payment of interest in shares (in Shares)	410,322
Stock-based compensation related to employees, directors and consultants		1,876					1,876
Issuance of shares upon early conversion of Convertible Debentures	$ 12	184					196
Issuance of shares upon early conversion of Convertible Debentures (in Shares)	280,876
Other comprehensive loss				590			590
Loss						(12,257)	(12,257)
Balance at Sep. 30, 2020	$ 2,376	258,177		(1,420)		(243,586)	15,547
Balance (in Shares) at Sep. 30, 2020	60,919,503
Balance at Jun. 30, 2020	$ 2,345	257,045		(2,011)		(238,694)	18,685
Balance (in Shares) at Jun. 30, 2020	60,197,223
Restricted stock units vested	$ 10	(10)
Restricted stock units vested (in Shares)	225,000
Payment of interest in shares	$ 12	276					288
Payment of interest in shares (in Shares)	280,946
Stock-based compensation related to employees, directors and consultants		724					724
Issuance of shares upon early conversion of Convertible Debentures	$ 9	142					151
Issuance of shares upon early conversion of Convertible Debentures (in Shares)	216,334
Other comprehensive loss				591			591
Loss						(4,892)	(4,892)
Balance at Sep. 30, 2020	$ 2,376	$ 258,177		$ (1,420)		$ (243,586)	$ 15,547
Balance (in Shares) at Sep. 30, 2020	60,919,503
[1]	Relates to foreign currency translation adjustments.

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Cash flows from operating activities:
Loss	$ (12,257)	$ (12,679)
Adjustments to reconcile loss to net cash used in operating activities:
Loss on disposal of property and equipment	12	1
Depreciation	1,809	1,420
Stock-based compensation	1,876	1,002
Amortization of intangible assets	2,071	2,736
Amortization of deferred commissions	1,181	(909)
Amortization of operating lease right-of-use assets	1,508	1,051
Interest on convertible notes	436	424
Interest and amortization of debt issuance costs on Convertible Debentures	400
Other expenses income related to the earn-out consideration		(257)
Deferred taxes, net	(171)	(182)
Changes in assets and liabilities:
Trade receivables	(126)	196
Prepaid expenses and other receivables	(456)	(607)
Deferred commissions	(900)	1,101
Change in long-term lease deposits	(89)	25
Trade payables	(289)	(264)
Employees and payroll accruals, accrued expenses and other liabilities	(90)	(185)
Deferred revenues	1,034	5,997
Accrued severance pay, net	(36)	73
Operating lease liabilities	(1,545)	(1,075)
Other long-term liabilities	184	(126)
Net cash used in operating activities	(5,448)	(2,258)
Cash flows from investing activities:
Proceeds from sale of property and equipment	6	1
Capitalization of technology	(1,100)	(2,462)
Purchase of property and equipment	(1,543)	(1,259)
Net cash used in investing activities	(2,637)	(3,720)
Cash flows from financing activities:
Proceeds from Convertible Debentures, net of debt issuance costs	9,442
Payment of earn-out consideration		(2,680)
Proceeds from options exercised		743
Net cash provided by (used in) financing activities	9,442	(1,937)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	(14)	(124)
Increase (decrease) in cash, cash equivalents and restricted cash	1,343	(8,039)
Cash, cash equivalents and restricted cash at the beginning of the period	12,127	18,156
Cash, cash equivalents and restricted cash at the end of the period	13,470	10,117
Cash paid during the year for:
Interest	144	553
Supplemental disclosure of non-cash transactions:
Purchase of property and equipment by credit	(214)	(1)
Operating lease right-of-use asset exchanged for lease obligations	3,772
Issuance of shares on early conversion of Convertible Debentures	196
Issuance of shares for payment of interest on convertible notes	431	71
Net change in accrued payroll expenses related to capitalization of technology	(26)	(259)
Reconciliation of cash, cash equivalents and restricted cash as shown in the condensed consolidated statements of cash flow:
Cash and cash equivalents	12,894	9,546
Restricted cash included in long-term restricted lease deposits	576	571
Total cash, cash equivalents and restricted cash	$ 13,470	$ 10,117

General

General	9 Months Ended
	Sep. 30, 2020
Share-based Payment Arrangement [Abstract]
GENERAL	NOTE 1:- GENERAL Cyren Ltd. (henceforth “Cyren”) was incorporated under the laws of the State of Israel on February 10, 1991 and its legal form is a company limited by shares. Cyren listed its shares to the public on July 15, 1999 under the name Commtouch Software Ltd. and changed its legal name to Cyren Ltd. in January 2014. Cyren and its subsidiaries, unless otherwise indicated will be referred to in these consolidated financial statements as the “Company”. The Company is a cybersecurity company providing email security and threat intelligence solutions. The Company sells its cloud-based solutions worldwide, in both embedded and Security-as-a-Service models, to Original Equipment Manufacturers (“OEMs”), service providers and enterprises. The Company operates in one reportable segment, which constitutes its reporting unit. Operating segments are defined as components of a business that can earn revenues and incur expenses for which discrete financial information is available that is evaluated regularly by the chief operating decision-maker (“CODM”). The Company’s CODM is its principal executive officer, who decides how to allocate resources and assess performance. A single management team reports to the CODM, who manages the entire business. The Company’s CODM reviews consolidated results of operations to make decisions, allocate resources and assess performance and does not evaluate the profit or loss from any separate geography or product line.

Significant Accounting Policies

Significant Accounting Policies	9 Months Ended
	Sep. 30, 2020
Accounting Policies [Abstract]
SIGNIFICANT ACCOUNTING POLICIES	NOTE 2:- SIGNIFICANT ACCOUNTING POLICIES a. Interim Financial Statements The accompanying consolidated balance sheet as of September 30, 2020, the consolidated statements of operations, the consolidated statements of comprehensive loss and the statement of changes in shareholders’ equity for the three and nine months ended September 30, 2020 and 2019, as well as the consolidated statements of cash flows for the nine months ended September 30, 2020 and 2019, are unaudited. These unaudited interim consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States (“U.S. GAAP”) and applicable rules and regulations of the Securities and Exchange Commission regarding interim financial reporting. In management’s opinion, the unaudited interim consolidated financial statements include all adjustments of a normal recurring nature necessary for the fair presentation of the Company’s financial position as of September 30, 2020, as well as its results of operations for the three and nine months ended September 30, 2020 and 2019. The results of operations for the three and nine months ended September 30, 2020 are not necessarily indicative of the results to be expected for the year ending December 31, 2020 or for other interim periods or for future years. b. The Company has incurred losses since inception and expects to continue to incur losses for the foreseeable future. At September 30, 2020, the Company’s cash and cash equivalents position is not sufficient to fund the Company’s planned operations for at least a year beyond the date of the issuance of the consolidated financial statements. Those factors raise substantial doubt about the Company’s ability to continue as a going concern. The ability to continue as a going concern is dependent upon the Company obtaining the necessary financing to meet its obligations and repay its liabilities arising from normal business operations when they become due. The Company intends to finance operating costs over the next twelve months through a combination of actions that may include existing cash on hand, reducing operating spend, divesting non-core assets and future issuances of equity and/or debt securities. The accompanying condensed consolidated financial statements have been prepared assuming the Company will continue as a going concern, which contemplates the realization of assets and liabilities and commitments in the normal course of business. The condensed consolidated financial statements for the three and nine months ended September 30, 2020 do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result from uncertainty related to the Company’s ability to continue as a going concern. c. Use of estimates: The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions. The Company’s management believes that the estimates, judgments and assumptions used are reasonable based upon information available at the time they are made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the interim consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. On an ongoing basis, the Company’s management evaluates estimates, including those related to fair value and useful lives of intangible assets, fair value of earn-out liabilities, valuation allowance on deferred tax assets, income tax uncertainties, fair values of stock-based awards, other contingent liabilities and estimates used in applying the revenue recognition policy. Such estimates are based on historical experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities. d. Significant accounting policies The accompanying unaudited interim financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission (the “SEC”) on March 30, 2020. Other than the change described below, there have been no changes to the significant accounting policies described in the Annual Report on Form 10-K for the fiscal year ended December 31, 2019 that have had a material impact on the unaudited interim consolidated financial statements and related notes. e. Recently issued and adopted pronouncements: In August 2018, the FASB issued ASU No. 2018-15, Intangibles—Goodwill and Other—Internal-Use Software (Subtopic 350-40): Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract (“ASU 2018-15”). ASU 2018-15 aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. The update to the standard is effective for interim and annual periods beginning after December 15, 2019, with early adoption permitted. Entities can choose to adopt the ASU 2018-15 prospectively or retrospectively. The adoption of the standard had an immaterial impact on the Condensed Consolidated Financial Statements. In January 2017, the FASB issued ASU 2017-04, Intangibles-Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment. ASU 2017-04 eliminates step two of the goodwill impairment test and specifies that goodwill impairment should be measured by comparing the fair value of a reporting unit with its carrying amount. Additionally, the amount of goodwill allocated to each reporting unit with a zero or negative carrying amount of net assets should be disclosed. ASU 2017-04 is effective for annual or interim goodwill impairment tests performed in fiscal years beginning after December 15, 2019, and early adoption is permitted. The adoption of the standard had an immaterial impact on the Condensed Consolidated Financial Statements. In June 2016, the FASB issued ASU 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. ASU 2016-13 amends the impairment model to utilize an expected loss methodology in place of the currently used incurred loss methodology, which will result in the more timely recognition of losses. This standard requires entities to estimate an expected lifetime credit loss on financial assets ranging from short-term trade accounts receivable to long-term financings and report credit losses using an expected losses model rather than the incurred losses model that was previously used. The new accounting standard was effective for the fiscal year beginning on January 1, 2020, including interim periods within that year. The adoption of the standard had an immaterial impact on the Condensed Consolidated Financial Statements.

Leases

Leases	9 Months Ended
	Sep. 30, 2020
Leases Disclosure [Abstract]
LEASES	NOTE 3:- LEASES The Company adopted the new standard as of January 1, 2019, using the modified retrospective approach. The modified retrospective approach provides a method for recording existing leases at adoption and in comparative periods that approximates the results of a full retrospective approach. The Company has elected to utilize the available package of practical expedients permitted under the transition guidance within the new standard which does not require it to reassess the prior conclusions about lease identification, lease classification and initial direct costs. In addition, the Company has elected the short-term lease exception for leases with a term of 12 months or less. As part of this election, it will not recognize right-of-use assets and lease liabilities on the balance sheet for leases with terms less than 12 months. The Company also elected the practical expedient to not separate lease and non-lease components for all our leases. This will result in the initial and subsequent measurement of the balances of the right-of-use asset and lease liability being greater than if the policy election was not applied. Some leases include one or more options to extend the lease. The exercise of options to extend the lease is typically at the Company’s sole discretion; therefore, the majority of renewals to extend the lease terms are included in our right of use assets and lease liabilities as they are reasonably certain of exercise. The Company regularly evaluates the renewal options, and, when it is reasonably certain of exercise, it will include the renewal period in its lease term. Lease modifications result in remeasurement of the lease liability. The right-of-use asset and lease liability are initially measured at the present value of the lease payments, discounted using the interest rate implicit in the lease or, if that rate cannot be readily determined, the Company’s incremental borrowing rate based on the information available at the date of adoption in determining the present value of the lease payments. Some of the real estate leases contain variable lease payments, including payments based on an index or rate. Variable lease payments based on an index or rate are initially measured using the index or rate in effect at lease adoption. Additional payments based on the change in an index or rate are recorded as a period expense when incurred. Income from subleased properties is recognized and presented as a reduction of costs, allocated among operating expense line items, in the Company’s Consolidated Statements of Operations and Comprehensive Loss. In addition to sublease rent, variable non-lease costs such as common-area maintenance and utilities are charged to subtenants throughout the lease for their proportionate share of these costs. These variable non-lease income receipts are recognized in operating expenses as a reduction to costs incurred by the Company in relation to the head lease. The Company has various operating leases for office space and vehicles that expire through 2030. Below is a summary of our operating right-of-use assets and operating lease liabilities as of September 30, 2020: Operating lease right-of-use assets $ 11,191 Operating lease liabilities, current $ 1,889 Operating lease liabilities long-term 9,678 Total operating lease liabilities $ 11,567 The short-term lease liabilities are included within accrued expenses and other short-term liabilities in the consolidated balance sheet. Minimum lease payments for our right of use assets over the remaining lease periods as of September 30, 2020, are as follows: Year ended December 31, 2020 $ 593 2021 2,305 2022 1,721 2023 1,527 2024 1,548 Thereafter 5,813 Total undiscounted lease payments $ 13,507 Less: Interest 1,940 Present value of lease liabilities $ 11,567 Premises rent expense was $714 and $575 for the three months ended September 30, 2020 and 2019, respectively and $2,100 and $1,676 for the nine months ended September 30, 2020 and 2019, respectively. As of September 30, 2020, Cyren subleases two real estate properties. Sublease receipts were $171 and $69 for the three months ended September 30, 2020 and 2019 respectively and $361 and $207 for the nine months ended September 30, 2020 and 2019, respectively. The Company has elected the practical expedient to not separate lease components from non-lease components. The weighted-average remaining lease terms and discount rates for all of operating leases were as follows as of September 30, 2020: Remaining lease term and discount rate: Weighted-average remaining lease term (years) 7.3 Weighted-average discount rate 4.37 %

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Sep. 30, 2020
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	NOTE 4:- COMMITMENTS AND CONTINGENCIES a. Cyren Ltd., which was incorporated in Israel, partially financed its research and development expenditures under programs sponsored by the Israel Innovation Authority (“IIA”) for the support of certain research and development activities conducted in Israel. In connection with specific research and development, the Company received $3,699 of participation payments from the IIA through September 30, 2020, but no grants since 2018. In return for the IIA’s participation in this program, the Company is committed to paying royalties at a rate of 3.0% of the program’s developed product sales, up to 100% of the amount of grants received plus interest at annual LIBOR rate. The Company’s total commitment for royalties payable with respect to future sales, based on IIA participations received, net of royalties paid or accrued, totaled $2,713 and $2,765 as of September 30, 2020 and December 31, 2019 respectively. For the three months ended, September 30, 2020 and 2019, $64 and $65, respectively, were recorded as cost of revenues with respect to royalties due to the IIA. For the nine months ended, September 30, 2020 and 2019, $173 and $201, respectively, were recorded as cost of revenues with respect to royalties due to the IIA. b. Litigation: i. Between 2014 and 2015 the Company entered into arbitral proceedings with the former shareholders of eleven regarding an escrow account and the earn-out consideration related to the purchase agreement of former eleven. With respect to these claims, on March 9, 2017, the arbitrational panel provided their ruling in which it accepted the claims submitted by the former eleven shareholders with respect to the escrow amount and the 2013 earn-out liability. The arbitrational panel also ruled that Cyren pay legal expenses and interest on the claimed amounts, which were reflected in the year ended December 31, 2016 on the Company’s balance sheet and in the consolidated statements of operations under adjustment to earn-out consideration. The escrow account has been released to the former shareholders. The arbitrational award related to the 2013 earn-out consideration was declared enforceable by the applicable courts in Germany. Accordingly, on May 30, 2018, the Company paid the portion of the earn-out consideration in the amount of $604 that was declared enforceable by the German district court. The Company did not pay the remainder of the earn-out consideration, including accrued legal and interest, which appear on the Company’s consolidated balance sheets as of December 31, 2018, and filed an appeal to the German Federal Supreme Court challenging the enforceability of the remaining amounts. In February 2019, the parties signed a settlement agreement to resolve all pending claims, and on February 28, 2019 the Company paid $2,680 to settle the earn-out consideration in full. The total amount paid to resolve all claims was $256 less than the accrued liability, which generated “other income” as previously reflected in the consolidated statements of operations for the period ended December 31, 2019. ii. On June 28, 2017 a vendor filed a Statement of Claim in the Tel Aviv District Court (the “SOC”). According to the vendor’s SOC, the Company entered into an agreement with the vendor for receipt of services, based on a database developed by the vendor. In September 2015, the Company terminated the agreement with the vendor, effective as of December 31, 2015. The vendor claimed that the Company had continued to make use of the vendor’s database post termination thus breaching the agreement, infringing on the vendor’s rights and commercial secrets, and being unjustly enriched. The vendor claimed damages of approximately $3,150 and injunctive relief ordering the Company and/or its customers to delete any remaining data and to cease from utilizing such data. The Company denied all claims and filed a Statement of Defense on November 15, 2017. Pretrial was scheduled for May 15, 2018. In accordance with the court’s recommendation from November 28, 2017, the parties agreed to examine a non-binding mediation process and appointed a mediator. The parties agreed to conduct a third-party audit of the Company’s databases in the scope of the mediation. In September 2018 and January 2019, the same vendor filed a lawsuit against two of the Company’s customers in the United States. The vendor alleged that the clients misappropriated the vendor’s trade secrets and sought injunctive relief and monetary damages in an amount to be determined. Both customers contended that the allegations related to the services they receive from the Company, and the Company agreed to indemnify both clients against these claims. On September 30, 2019, the court dismissed one of the lawsuits in its entirety for lack of personal jurisdiction and, in the second lawsuit, dismissed part of the claims with prejudice but granted the vendor the right to amend its other claims. On October 31, 2019, the vendor filed an amended complaint. In December 2019, the Company reached a settlement with the vendor and the Company agreed to pay $750; $375 in December 2019 and the remaining portion in January 2020. As of September 30, 2020, the Company has paid all amounts due under this settlement.

Shareholders' Equity

Shareholders' Equity	9 Months Ended
	Sep. 30, 2020
Stockholders' Equity Note [Abstract]
SHAREHOLDERS’ EQUITY	NOTE 5:- ShareHOLDERS’ EQUITY a. General: Ordinary shares confer upon their holders the right to receive notice to participate and vote in general shareholder meetings of the Company and to receive dividends, if declared. b. Issuance of convertible notes: On December 5, 2018 the Company issued $10,000 aggregate principal amount of convertible notes in a private offering. The notes are unsecured, unsubordinated obligations of Cyren and carry a 5.75% interest rate, payable semi-annually in (i) 50% cash and (ii) 50% cash or ordinary shares at Cyren’s election. The notes have a 3-year term and are expected to mature in December 2021, unless converted in accordance with their terms prior to maturity. The notes were issued with a conversion price of $3.90 per share which was subject to adjustment using a weighted-average ratchet mechanism based on the size and price of future equity offerings and the total shares outstanding. On November 7, 2019 Cyren announced the closing of a rights offering that raised gross proceeds of $8,019. As a result of this offering, the conversion price of the convertible notes was adjusted to $3.73. In addition, the notes would be subject to immediate conversion upon any change in control in the Company (or subject to repayment if the price in the change in control transaction is less than the conversion price). During the nine months ended, September 30, 2020, the Company paid semi-annual interest payments totaling, $288, of which $144 was paid in cash and the remaining portion through the issuance of 129,376 shares. The Company has accrued interest of $181 as of September 30, 2020. The principal balance of the convertible notes as of September 30, 2020 was $10.0 million. c. Issuance of Convertible Debentures: In March 2020, the Company entered into purchase agreements with a select group of accredited investors for the purchase of $10.25 million aggregate principal amount of Convertible Debentures in a private placement. Upon the closing, the Company received approximately $9.4 million (net of $0.8 million in issuance expenses). The debentures are unsecured, subordinated obligations of Cyren and carry a 5.75% interest rate per annum, payable semi-annually in cash or ordinary shares at Cyren’s election. The debentures have a four-year term and mature in March 2024, unless converted in accordance with their terms prior to maturity. The debentures have a conversion price of $0.75 per share and are convertible into 1,333 ordinary shares per $1,000 principal amount of debentures. The conversion price is subject to adjustment based on the price and timing of future equity offerings and other customary adjustments. Upon the satisfaction of price and other conditions, Cyren has the right to force the conversion of the debentures. In September 2020, the Company paid semi-annual interest payments totaling, $289, which was paid through the issuance of 280,946 shares. On July 6, 2020, one of the debenture holders converted $163 of principal plus interest of their debentures, which was a portion of their holding. The principal and interest were paid through the issuance of 216,334 shares. The Company has accrued interest of $13 as of September 30, 2020. The principal balance of the Convertible Debentures as of September 30, 2020 was $10.04 million. d. Equity Incentive Plan: On December 22, 2016, the Company’s shareholders approved a new equity plan - the 2016 Equity Incentive Plan (the “Equity Incentive Plan”). This plan, along with its respective Israeli appendix, replaced all then-existing employee and consultants stock option plans. The Equity Incentive Plan allows for the issuance of Restricted Stock Units (“RSUs”), as well as options. The options and RSUs generally vest over a period of four years. Options granted under the Equity Incentive Plan generally expire after six years from the date of grant. Options and RSUs cease vesting upon termination of the optionee’s employment or other relationship with the Company. The per share exercise price for options shall be no less than 100% of the fair market value per ordinary share on the date of grant. Any options and RSUs that are cancelled or not exercised within the option term become available for future grant. On July 30, 2019, the shareholders of the Company approved an increase in the number of Ordinary Shares reserved for issuance under the 2016 Equity Incentive Plan and its respective Israeli Appendix to a total of 11,200,000. As of September 30, 2020, an aggregate of 7,362,861 ordinary shares of the Company are still available for future grant under the Equity Incentive Plan. e. Non-Employee Directors stock option plan: On December 22, 2016, the Company’s shareholders approved a new equity plan - the 2016 Non-Employee Director Equity Incentive Plan (the “Non-Employee Director Plan”). This plan, along with its respective Israeli appendix, replaced all existing Directors stock option plans. The Non-Employee Director Plan allows for the issuance of Restricted Stock Units (“RSUs”), as well as options. Each option and RSU granted under the Non-Employee Plan generally vests over a period of four years. Each option has an exercise price equal to the fair market value of the ordinary shares on the grant date of such option. Options granted under the Non-Employee Director Plan generally expire after six years from the date of grant. Options and RSUs cease vesting upon termination of the relationship with the Company. On July 30, 2019 the shareholders of the Company approved an increase in the number of Ordinary Shares reserved for issuance under the Non-Employee Director Plan and its respective Israeli Appendix to a total of 1,150,000 Ordinary Shares. As of September 30, 2020, an aggregate of 797,882 ordinary shares of the Company are still available for future grant to non-employee directors. f. A summary of the Company’s employees and directors’ stock option activity under the plans is as follows: Number of Weighted- Weighted- Aggregate Outstanding at December 31, 2019 7,299,667 $ 2.16 3.81 $ - Granted 235,500 1.50 Exercised - - Expired and forfeited (1,152,674 ) 2.49 Outstanding at September 30, 2020 6,382,493 $ 2.08 3.40 $ 1 Options vested and expected to vest at September 30, 2020 6,183,575 $ 2.09 3.36 $ 1 Exercisable options at September 30, 2020 3,879,279 $ 2.19 2.55 $ - Weighted-average fair value of options granted during the quarter $ 0.66 As of September 30, 2020, the Company had $1,911 of unrecognized compensation expense related to non-vested stock options granted to employees and directors, expected to be recognized over a remaining weighted-average period of 2.46 years. g. The employee and director options outstanding as of September 30, 2020, have been separated into ranges of exercise prices, as follows: Outstanding Exercisable Weighted- Weighted- Weighted- Options life in price per Options price per Exercise price per share outstanding years share exercisable share $1.06 - $1.64 1,568,415 4.03 $ 1.56 752,090 $ 1.52 $1.70 - $2.00 1,642,110 3.59 $ 1.85 1,084,118 $ 1.92 $2.05 - $2.14 1,336,568 4.39 $ 2.09 601,928 $ 2.10 $2.30 - $2.75 781,400 3.77 $ 2.39 477,169 $ 2.38 $2.90 - $3.20 1,054,000 2.18 $ 2.97 963,974 $ 2.97 6,382,493 3.65 $ 2.08 3,879,279 $ 2.19 h. Options to non-employees and non-directors: Issuance date Options Exercise Options Exercisable February 18, 2015 3,000 $ 3.00 3,000 Feb-21 February 10, 2016 40,000 $ 1.44 40,000 Feb-22 January 24, 2017 25,000 $ 2.00 25,000 Jan-23 68,000 68,000 The options vest and become exercisable at a rate of 1/16 of the options every three months. As of September 30, 2020, the Company did not have any unrecognized compensation expense related to non-employee and non-director non-vested stock options. i. A summary of the Company’s RSUs activity for employees, directors and non-employees under the plans is as follows: Number Weighted- average Awarded and unvested at December 31, 2019 1,733,132 $ 2.09 Granted 1,359,000 1.28 Vested (856,132 ) 2.30 Forfeited (42,500 ) 2.30 Awarded and unvested at September 30, 2020 2,193,500 $ 1.50 As of September 30, 2020, the Company had approximately $2,706 of unrecognized compensation expense related to RSUs, expected to be recognized over a weighted-average period of 2.72 years. j. The total stock-based compensation expense related to all of the Company’s equity-based awards, recognized for the three and nine months ended September 30, 2020 and 2019 was as follows: Three months ended Nine months ended 2020 2019 2020 2019 Unaudited Unaudited Cost of revenues $ 21 $ 36 $ 85 98 Research and development 70 78 229 203 Sales and marketing 65 51 204 148 General and administrative 568 254 1,358 553 $ 724 $ 419 $ 1,876 $ 1,002

Segment and Geographic Informat

Segment and Geographic Information	9 Months Ended
	Sep. 30, 2020
Segment Reporting [Abstract]
SEGMENT AND GEOGRAPHIC INFORMATION	NOTE 6:- SEGMENT AND GEOGRAPHIC INFORMATION Summary information about geographic areas: ASC 280, “Segment Reporting,” establishes standards for reporting information about operating segments. Operating segments are defined as components of an enterprise about which separate financial information is available that is evaluated regularly by the chief operating decision-maker in deciding how to allocate resources and in assessing performance. The Company manages its business on the basis of one reportable segment and derives revenues from licensing of software and sales of professional services, maintenance and technical support (see note 1 for a brief description of the Company’s business). The following is a summary of revenues within geographic areas: a. The following sets forth total revenue by geographic area based on the billing address of the customer: Three months ended Nine months ended 2020 2019 2020 2019 United States $ 4,201 $ 4,470 $ 13,075 $ 13,552 Germany 2,109 2,153 6,269 6,617 Europe-Other 966 890 2,993 2,573 Asia Pacific 667 661 1,900 1,930 Israel 1,001 1,251 3,350 3,971 Other 170 71 357 219 $ 9,114 $ 9,496 $ 27,944 $ 28,862 b. Major customers: During the quarter ended September 30, 2020 and 2019, 22% and 20%, respectively, of the Company’s revenues were derived from a single customer. After quarter-end we signed two additional agreements that will increase revenues from this customer during the fourth quarter of 2020 and the first quarter of 2021. We also received notification that this customer will renew one of their contracts for another three years through the first quarter of 2024, but that it does not intend to renew its largest contract with the Company at full value beginning in April 2021. As a result, we anticipate that quarterly revenues from this customer will drop from over 20% currently to approximately 12% of quarterly revenue beginning in the second quarter of 2021. For the quarter ended September 30, 2020, no other customer accounted for more than 10% of total revenue. c. Remaining performance obligations: As of September 30, 2020, approximately $40,695 of revenue is expected to be recognized from remaining performance obligations that are unsatisfied (or partially unsatisfied) for non-cancellable contracts. The Company expects to recognize revenue on approximately 22% of these remaining performance obligations during the remainder of 2020, approximately 53% in 2021, with the remainder recognized thereafter. c. Revenue generated by Customer Type: Three months ended Nine months ended 2020 2019 2020 2019 Unaudited Unaudited OEM/Embedded Security (*) $ 7,354 $ 7,691 $ 22,771 $ 23,363 Enterprise/SMB (**) 1,760 1,805 5,173 5,499 $ 9,114 $ 9,496 $ 27,944 $ 28,862 (*) This market represents customers who embed Cyren Threat Detection Services and Threat Intelligence Feeds into their infrastructure and/or products to protect their customers and users. (**) In this market, Cyren provides enterprise customers email security products, threat intelligence and cloud-based sandbox threat analysis to protect their employees, data and IP. d. The following sets forth the Company’s property and equipment by geographic area: September 30, December 31 2020 2019 Unaudited Israel $ 1,063 $ 1,291 United States 1,439 1,527 Germany 1,735 1,345 Other 173 247 $ 4,410 $ 4,410

Financial Expense, Net

Financial Expense, Net	9 Months Ended
	Sep. 30, 2020
Other Income and Expenses [Abstract]
FINANCIAL EXPENSE, NET	NOTE 7:- FINANCIAL EXPENSE, NET Three months ended Nine months ended 2020 2019 2020 2019 Income: Interest on cash and cash equivalents $ - $ 1 $ - $ 22 Expenses: Interest expense, net of interest capitalized (410 ) (92 ) (902 ) (307 ) Foreign currency exchange differences, net 189 (218 ) 196 (311 ) Other (15 ) (12 ) (51 ) (46 ) $ (236 ) $ (321 ) $ (757 ) $ (642 )

Related Parties

Related Parties	9 Months Ended
	Sep. 30, 2020
Related Party Transactions [Abstract]
RELATED PARTIES	NOTE 8:- RELATED PARTIES a. Balances with related parties: September 30, December 31, 2020 2019 Unaudited Interest expense accrual – Convertible Notes (*) $ 181 $ 32 Long term Convertible Notes (**) 10,000 10,000 Long term Convertible Debentures (***) 233 - (*) Related to the semi-annual interest payments due in June and December related to the Convertible Notes entered into December 5, 2018. See note 5b. for further details. (**) Related to the Convertible Notes entered into December 5, 2018. See note 5b. for further details. (***) Related to the Convertible Debentures entered into March 19, 2020 See note 5c. for further details. b. Transactions with related parties: Three months ended Nine months ended 2020 2019 2020 2019 Unaudited Unaudited Interest expense on Convertible Notes (*) $ 153 $ 141 $ 436 $ 424 Interest expense on Convertible Debentures (**) $ 5 $ - $ 10 $ - (*) Related to the semi-annual interest payments due in June and December related to the Convertible Notes entered into December 5, 2018. See note 5b. for further details. (**) Related to the semi-annual interest payments due in September and March related to the Convertible Debentures entered into March 19, 2020. See note 5c. for further details.

Accounting Policies, by Policy

Accounting Policies, by Policy (Policies)	9 Months Ended
	Sep. 30, 2020
Accounting Policies [Abstract]
Interim Financial Statements	a. Interim Financial Statements The accompanying consolidated balance sheet as of September 30, 2020, the consolidated statements of operations, the consolidated statements of comprehensive loss and the statement of changes in shareholders’ equity for the three and nine months ended September 30, 2020 and 2019, as well as the consolidated statements of cash flows for the nine months ended September 30, 2020 and 2019, are unaudited. These unaudited interim consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States (“U.S. GAAP”) and applicable rules and regulations of the Securities and Exchange Commission regarding interim financial reporting. In management’s opinion, the unaudited interim consolidated financial statements include all adjustments of a normal recurring nature necessary for the fair presentation of the Company’s financial position as of September 30, 2020, as well as its results of operations for the three and nine months ended September 30, 2020 and 2019. The results of operations for the three and nine months ended September 30, 2020 are not necessarily indicative of the results to be expected for the year ending December 31, 2020 or for other interim periods or for future years. b. The Company has incurred losses since inception and expects to continue to incur losses for the foreseeable future. At September 30, 2020, the Company’s cash and cash equivalents position is not sufficient to fund the Company’s planned operations for at least a year beyond the date of the issuance of the consolidated financial statements. Those factors raise substantial doubt about the Company’s ability to continue as a going concern. The ability to continue as a going concern is dependent upon the Company obtaining the necessary financing to meet its obligations and repay its liabilities arising from normal business operations when they become due. The Company intends to finance operating costs over the next twelve months through a combination of actions that may include existing cash on hand, reducing operating spend, divesting non-core assets and future issuances of equity and/or debt securities. The accompanying condensed consolidated financial statements have been prepared assuming the Company will continue as a going concern, which contemplates the realization of assets and liabilities and commitments in the normal course of business. The condensed consolidated financial statements for the three and nine months ended September 30, 2020 do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result from uncertainty related to the Company’s ability to continue as a going concern.
Use of estimates	c. Use of estimates: The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions. The Company’s management believes that the estimates, judgments and assumptions used are reasonable based upon information available at the time they are made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the interim consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. On an ongoing basis, the Company’s management evaluates estimates, including those related to fair value and useful lives of intangible assets, fair value of earn-out liabilities, valuation allowance on deferred tax assets, income tax uncertainties, fair values of stock-based awards, other contingent liabilities and estimates used in applying the revenue recognition policy. Such estimates are based on historical experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities.
Significant accounting policies	d. Significant accounting policies The accompanying unaudited interim financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission (the “SEC”) on March 30, 2020. Other than the change described below, there have been no changes to the significant accounting policies described in the Annual Report on Form 10-K for the fiscal year ended December 31, 2019 that have had a material impact on the unaudited interim consolidated financial statements and related notes.
Recently issued and adopted pronouncements	e. Recently issued and adopted pronouncements: In August 2018, the FASB issued ASU No. 2018-15, Intangibles—Goodwill and Other—Internal-Use Software (Subtopic 350-40): Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract (“ASU 2018-15”). ASU 2018-15 aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. The update to the standard is effective for interim and annual periods beginning after December 15, 2019, with early adoption permitted. Entities can choose to adopt the ASU 2018-15 prospectively or retrospectively. The adoption of the standard had an immaterial impact on the Condensed Consolidated Financial Statements. In January 2017, the FASB issued ASU 2017-04, Intangibles-Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment. ASU 2017-04 eliminates step two of the goodwill impairment test and specifies that goodwill impairment should be measured by comparing the fair value of a reporting unit with its carrying amount. Additionally, the amount of goodwill allocated to each reporting unit with a zero or negative carrying amount of net assets should be disclosed. ASU 2017-04 is effective for annual or interim goodwill impairment tests performed in fiscal years beginning after December 15, 2019, and early adoption is permitted. The adoption of the standard had an immaterial impact on the Condensed Consolidated Financial Statements. In June 2016, the FASB issued ASU 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. ASU 2016-13 amends the impairment model to utilize an expected loss methodology in place of the currently used incurred loss methodology, which will result in the more timely recognition of losses. This standard requires entities to estimate an expected lifetime credit loss on financial assets ranging from short-term trade accounts receivable to long-term financings and report credit losses using an expected losses model rather than the incurred losses model that was previously used. The new accounting standard was effective for the fiscal year beginning on January 1, 2020, including interim periods within that year. The adoption of the standard had an immaterial impact on the Condensed Consolidated Financial Statements.

Leases (Tables)

Leases (Tables)	9 Months Ended
	Sep. 30, 2020
Leases Disclosure [Abstract]
Schedule of operating right-of-use assets and operating lease liabilities	Operating lease right-of-use assets $ 11,191 Operating lease liabilities, current $ 1,889 Operating lease liabilities long-term 9,678 Total operating lease liabilities $ 11,567
Schedule of future minimum lease payments	Year ended December 31, 2020 $ 593 2021 2,305 2022 1,721 2023 1,527 2024 1,548 Thereafter 5,813 Total undiscounted lease payments $ 13,507 Less: Interest 1,940 Present value of lease liabilities $ 11,567
Schedule of weighted average remaining lease terms and discount rates for all of operating leases	Remaining lease term and discount rate: Weighted-average remaining lease term (years) 7.3 Weighted-average discount rate 4.37 %

Shareholders' Equity (Tables)

Shareholders' Equity (Tables)	9 Months Ended
	Sep. 30, 2020
Stockholders' Equity Note [Abstract]
Schedule of employees and directors' stock option activity	Number of Weighted- Weighted- Aggregate Outstanding at December 31, 2019 7,299,667 $ 2.16 3.81 $ - Granted 235,500 1.50 Exercised - - Expired and forfeited (1,152,674 ) 2.49 Outstanding at September 30, 2020 6,382,493 $ 2.08 3.40 $ 1 Options vested and expected to vest at September 30, 2020 6,183,575 $ 2.09 3.36 $ 1 Exercisable options at September 30, 2020 3,879,279 $ 2.19 2.55 $ - Weighted-average fair value of options granted during the quarter $ 0.66
Schedule of employee and director options outstanding	Outstanding Exercisable Weighted- Weighted- Weighted- Options life in price per Options price per Exercise price per share outstanding years share exercisable share $1.06 - $1.64 1,568,415 4.03 $ 1.56 752,090 $ 1.52 $1.70 - $2.00 1,642,110 3.59 $ 1.85 1,084,118 $ 1.92 $2.05 - $2.14 1,336,568 4.39 $ 2.09 601,928 $ 2.10 $2.30 - $2.75 781,400 3.77 $ 2.39 477,169 $ 2.38 $2.90 - $3.20 1,054,000 2.18 $ 2.97 963,974 $ 2.97 6,382,493 3.65 $ 2.08 3,879,279 $ 2.19
Schedule of options to non-employees	Issuance date Options Exercise Options Exercisable February 18, 2015 3,000 $ 3.00 3,000 Feb-21 February 10, 2016 40,000 $ 1.44 40,000 Feb-22 January 24, 2017 25,000 $ 2.00 25,000 Jan-23 68,000 68,000
Schedule of RSUs activity	Number Weighted- average Awarded and unvested at December 31, 2019 1,733,132 $ 2.09 Granted 1,359,000 1.28 Vested (856,132 ) 2.30 Forfeited (42,500 ) 2.30 Awarded and unvested at September 30, 2020 2,193,500 $ 1.50
Schedule of stock-based compensation expense	Three months ended Nine months ended 2020 2019 2020 2019 Unaudited Unaudited Cost of revenues $ 21 $ 36 $ 85 98 Research and development 70 78 229 203 Sales and marketing 65 51 204 148 General and administrative 568 254 1,358 553 $ 724 $ 419 $ 1,876 $ 1,002

Segment and Geographic Inform_2

Segment and Geographic Information (Tables)	9 Months Ended
	Sep. 30, 2020
Segment Reporting [Abstract]
Schedule of total revenue by geographic area	Three months ended Nine months ended 2020 2019 2020 2019 United States $ 4,201 $ 4,470 $ 13,075 $ 13,552 Germany 2,109 2,153 6,269 6,617 Europe-Other 966 890 2,993 2,573 Asia Pacific 667 661 1,900 1,930 Israel 1,001 1,251 3,350 3,971 Other 170 71 357 219 $ 9,114 $ 9,496 $ 27,944 $ 28,862
Schedule of revenue generated by Customer Type	Three months ended Nine months ended 2020 2019 2020 2019 Unaudited Unaudited OEM/Embedded Security (*) $ 7,354 $ 7,691 $ 22,771 $ 23,363 Enterprise/SMB (**) 1,760 1,805 5,173 5,499 $ 9,114 $ 9,496 $ 27,944 $ 28,862 (*) This market represents customers who embed Cyren Threat Detection Services and Threat Intelligence Feeds into their infrastructure and/or products to protect their customers and users. (**) In this market, Cyren provides enterprise customers email security products, threat intelligence and cloud-based sandbox threat analysis to protect their employees, data and IP.
Schedule of net amount of property and equipment	September 30, December 31 2020 2019 Unaudited Israel $ 1,063 $ 1,291 United States 1,439 1,527 Germany 1,735 1,345 Other 173 247 $ 4,410 $ 4,410

Financial Expense, Net (Tables)

Financial Expense, Net (Tables)	9 Months Ended
	Sep. 30, 2020
Other Income and Expenses [Abstract]
Schedule of financial expense, net	Three months ended Nine months ended 2020 2019 2020 2019 Income: Interest on cash and cash equivalents $ - $ 1 $ - $ 22 Expenses: Interest expense, net of interest capitalized (410 ) (92 ) (902 ) (307 ) Foreign currency exchange differences, net 189 (218 ) 196 (311 ) Other (15 ) (12 ) (51 ) (46 ) $ (236 ) $ (321 ) $ (757 ) $ (642 )

Related Parties (Tables)

Related Parties (Tables)	9 Months Ended
	Sep. 30, 2020
Related Party Transactions [Abstract]
Schedule of balances with related parties	September 30, December 31, 2020 2019 Unaudited Interest expense accrual – Convertible Notes (*) $ 181 $ 32 Long term Convertible Notes (**) 10,000 10,000 Long term Convertible Debentures (***) 233 - (*) Related to the semi-annual interest payments due in June and December related to the Convertible Notes entered into December 5, 2018. See note 5b. for further details. (**) Related to the Convertible Notes entered into December 5, 2018. See note 5b. for further details. (***) Related to the Convertible Debentures entered into March 19, 2020 See note 5c. for further details.
Schedule of transactions with related parties	Three months ended Nine months ended 2020 2019 2020 2019 Unaudited Unaudited Interest expense on Convertible Notes (*) $ 153 $ 141 $ 436 $ 424 Interest expense on Convertible Debentures (**) $ 5 $ - $ 10 $ - (*) Related to the semi-annual interest payments due in June and December related to the Convertible Notes entered into December 5, 2018. See note 5b. for further details. (**) Related to the semi-annual interest payments due in September and March related to the Convertible Debentures entered into March 19, 2020. See note 5c. for further details.

Leases (Details)

Leases (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Leases Disclosure [Abstract]
Leases, description			The Company has various operating leases for office space and vehicles that expire through 2030.
Premises rent expense	$ 714	$ 575	$ 2,100	$ 1,676
Sublease receipts	$ 171	$ 69	$ 361	$ 207

Leases (Details) - Schedule of

Leases (Details) - Schedule of operating right-of-use assets and operating lease liabilities - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019
Schedule of operating right-of-use assets and operating lease liabilities [Abstract]
Operating lease right-of-use assets	$ 11,191	$ 8,695
Operating lease liabilities, current	1,889	1,946
Operating lease liabilities long-term	9,678	$ 7,174
Total operating lease liabilities	$ 11,567

Leases (Details) - Schedule o_2

Leases (Details) - Schedule of future minimum lease payments $ in Thousands	Sep. 30, 2020USD ($)
Schedule of future minimum lease payments [Abstract]
2020	$ 593
2021	2,305
2022	1,721
2023	1,527
2024	1,548
Thereafter	5,813
Total undiscounted lease payments	13,507
Less: Interest	1,940
Present value of lease liabilities	$ 11,567

Leases (Details) - Schedule o_3

Leases (Details) - Schedule of weighted average remaining lease terms and discount rates for all of operating leases	Sep. 30, 2020
Remaining lease term and discount rate:
Weighted-average remaining lease term (years)	7 years 109 days
Weighted-average discount rate	4.37%

Commitments and Contingencies (

Commitments and Contingencies (Details) - USD ($) $ in Thousands	1 Months Ended		3 Months Ended		9 Months Ended		12 Months Ended
	Feb. 28, 2019	May 30, 2018	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2019
Commitments and Contingencies (Details) [Line Items]
Other Research and Development Expense					$ 3,699
Royalty rate					In return for the IIA’s participation in this program, the Company is committed to paying royalties at a rate of 3.0% of the program’s developed product sales, up to 100% of the amount of grants received plus interest at annual LIBOR rate.
Net of royalties paid or accrued					$ 2,713		$ 2,765
Cost of revenues with respect to royalties			$ 64	$ 65
Royalities due					173	$ 201
Payment of earn-out consideration						$ 2,680
Settle of earn-out consideration	$ 2,680
Claims settlement amount	$ 256
License fees					$ 3,150
Settlement agreement, description					the Company reached a settlement with the vendor and the Company agreed to pay $750; $375 in December 2019 and the remaining portion in January 2020. As of September 30, 2020, the Company has paid all amounts due under this settlement.
Majority Shareholder [Member]
Commitments and Contingencies (Details) [Line Items]
Payment of earn-out consideration		$ 604

Shareholders' Equity (Details)

Shareholders' Equity (Details) - USD ($)	1 Months Ended					9 Months Ended
	Jul. 06, 2020	Mar. 31, 2020	Jul. 30, 2019	Dec. 05, 2018	Nov. 07, 2018	Sep. 30, 2020	Sep. 30, 2019
Shareholders' Equity (Details) [Line Items]
Aggregate principal amount				$ 10,000
Interest rate				5.75%
Debt instrument, description	On July 6, 2020, one of the debenture holders converted $163 of principal plus interest of their debentures, which was a portion of their holding.			The notes have a 3-year term and are expected to mature in December 2021, unless converted in accordance with their terms prior to maturity. The notes were issued with a conversion price of $3.90 per share which was subject to adjustment using a weighted-average ratchet mechanism based on the size and price of future equity offerings and the total shares outstanding.
Gross proceeds					$ 8,019
Conversion price, per share (in Dollars per share)					$ 3.73
Interest expense						$ 436,000	$ 424,000
Cash						$ 144
Issuance of shares (in Shares)						129,376
Accrued interest						$ 181
Issuance expenses		$ 800,000
Principal and interest issuance of shares (in Shares)	216,334
Accrued interest						$ 13
Options grant/vest, description						The per share exercise price for options shall be no less than 100% of the fair market value per ordinary share on the date of grant. Any options and RSUs that are cancelled or not exercised within the option term become available for future grant.
Annual meeting, description			On July 30, 2019, the shareholders of the Company approved an increase in the number of Ordinary Shares reserved for issuance under the 2016 Equity Incentive Plan and its respective Israeli Appendix to a total of 11,200,000.
Ordinary shares available for future grant (in Shares)						7,362,861
Unrecognized compensation expense						$ 1,911
Recognized over remaining weighted average period						2 years 167 days
Options grant/vest, description						The options vest and become exercisable at a rate of 1/16 of the options every three months.
Issuance of convertible notes [Member]
Shareholders' Equity (Details) [Line Items]
Aggregate principal amount						$ 10,000,000
Interest expense						288
Convertible Notes Payable [Member]
Shareholders' Equity (Details) [Line Items]
Aggregate principal amount		10,250,000				$ 1,000
Interest rate						5.75%
Convertible Debentures [Member]
Shareholders' Equity (Details) [Line Items]
Aggregate principal amount		$ 9,400,000
Conversion price, per share (in Dollars per share)						$ 0.75
Convertible shares (in Shares)						1,333
Issuance of Convertible Debentures [Member]
Shareholders' Equity (Details) [Line Items]
Aggregate principal amount						$ 10,040,000
Interest expense						$ 289
Issuance of shares (in Shares)						280,946
Non-Employee Plan [Member]
Shareholders' Equity (Details) [Line Items]
Issuance of shares (in Shares)			1,150,000			797,882
Restricted Stock Units (RSUs) [Member]
Shareholders' Equity (Details) [Line Items]
Unrecognized compensation expense						$ 2,706
Recognized over remaining weighted average period						2 years 262 days

Shareholders' Equity (Details)

Shareholders' Equity (Details) - Schedule of employees and directors' stock option activity - Employees and directors' stock option [Member] $ / shares in Units, $ in Thousands	9 Months Ended
	Sep. 30, 2020USD ($)$ / sharesshares
Shareholders' Equity (Details) - Schedule of employees and directors' stock option activity [Line Items]
Outstanding, Beginning balance (in Shares) | shares	7,299,667
Outstanding, Beginning	$ 2.16
Outstanding, Beginning balance	3 years 295 days
Outstanding, Beginning balance (in Dollars) | $
Granted (in Shares) | shares	235,500
Granted	$ 1.50
Exercised (in Shares) | shares
Exercised
Expired and forfeited (in Shares) | shares	(1,152,674)
Expired and forfeited	$ 2.49
Outstanding, Ending balance (in Shares) | shares	6,382,493
Outstanding, Ending balance	$ 2.08
Outstanding, Ending balance	3 years 146 days
Outstanding, Ending balance (in Dollars) | $	$ 1
Options vested and expected to vest (in Shares) | shares	6,183,575
Options vested and expected to vest	$ 2.09
Options vested and expected to vest	3 years 131 days
Options vested and expected to vest (in Dollars) | $	$ 1
Exercisable options (in Shares) | shares	3,879,279
Exercisable options	$ 2.19
Exercisable options	2 years 200 days
Exercisable options (in Dollars) | $
Weighted average fair value of options granted during the quarter	$ 0.66

Shareholders' Equity (Details_2

Shareholders' Equity (Details) - Schedule of employee and director options outstanding	9 Months Ended
	Sep. 30, 2020$ / sharesshares
Range One [Member]
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Outstanding, Exercise price per share, lower limit	$ 1.06
Outstanding, Exercise price per share, upper limit	$ 1.64
Outstanding, Options outstanding (in Shares) | shares	1,568,415
Outstanding, Weighted average remaining contractual life in years	4 years 10 days
Outstanding, Weighted average exercise price per share	$ 1.56
Exercisable, Options exercisable (in Shares) | shares	752,090
Exercisable, Weighted average exercise price per share	$ 1.52
Range Two [Member]
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Outstanding, Exercise price per share, lower limit	1.70
Outstanding, Exercise price per share, upper limit	$ 2
Outstanding, Options outstanding (in Shares) | shares	1,642,110
Outstanding, Weighted average remaining contractual life in years	3 years 215 days
Outstanding, Weighted average exercise price per share	$ 1.85
Exercisable, Options exercisable (in Shares) | shares	1,084,118
Exercisable, Weighted average exercise price per share	$ 1.92
Range Three [Member]
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Outstanding, Exercise price per share, lower limit	2.05
Outstanding, Exercise price per share, upper limit	$ 2.14
Outstanding, Options outstanding (in Shares) | shares	1,336,568
Outstanding, Weighted average remaining contractual life in years	4 years 142 days
Outstanding, Weighted average exercise price per share	$ 2.09
Exercisable, Options exercisable (in Shares) | shares	601,928
Exercisable, Weighted average exercise price per share	$ 2.10
Range Four [Member]
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Outstanding, Exercise price per share, lower limit	2.30
Outstanding, Exercise price per share, upper limit	$ 2.75
Outstanding, Options outstanding (in Shares) | shares	781,400
Outstanding, Weighted average remaining contractual life in years	3 years 281 days
Outstanding, Weighted average exercise price per share	$ 2.39
Exercisable, Options exercisable (in Shares) | shares	477,169
Exercisable, Weighted average exercise price per share	$ 2.38
Range Five [Member]
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Outstanding, Exercise price per share, lower limit	2.90
Outstanding, Exercise price per share, upper limit	$ 3.20
Outstanding, Options outstanding (in Shares) | shares	1,054,000
Outstanding, Weighted average remaining contractual life in years	2 years 65 days
Outstanding, Weighted average exercise price per share	$ 2.97
Exercisable, Options exercisable (in Shares) | shares	963,974
Exercisable, Weighted average exercise price per share	$ 2.97
Range Six [Member]
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Outstanding, Options outstanding (in Shares) | shares	6,382,493
Outstanding, Weighted average remaining contractual life in years	3 years 237 days
Outstanding, Weighted average exercise price per share	$ 2.08
Exercisable, Options exercisable (in Shares) | shares	3,879,279
Exercisable, Weighted average exercise price per share	$ 2.19

Shareholders' Equity (Details_3

Shareholders' Equity (Details) - Schedule of options to non-employees	9 Months Ended
	Sep. 30, 2020$ / sharesshares
Issuance Date Two [Member]
Shareholders' Equity (Details) - Schedule of options to non-employees [Line Items]
Issuance date	Feb. 18, 2015
Options outstanding	3,000
Exercise price per share (in Dollars per share) | $ / shares	$ 3
Options exercisable	3,000
Exercisable through	Feb-21
Issuance Date Three [Member]
Shareholders' Equity (Details) - Schedule of options to non-employees [Line Items]
Issuance date	Feb. 10, 2016
Options outstanding	40,000
Exercise price per share (in Dollars per share) | $ / shares	$ 1.44
Options exercisable	40,000
Exercisable through	Feb-22
Issuance Date Four [Member]
Shareholders' Equity (Details) - Schedule of options to non-employees [Line Items]
Issuance date	Jan. 24, 2017
Options outstanding	25,000
Exercise price per share (in Dollars per share) | $ / shares	$ 2
Options exercisable	25,000
Exercisable through	Jan-23
Issuance Date Five [Member]
Shareholders' Equity (Details) - Schedule of options to non-employees [Line Items]
Options outstanding	68,000
Options exercisable	68,000

Shareholders' Equity (Details_4

Shareholders' Equity (Details) - Schedule of RSUs activity - Restricted Stock Units (RSUs) [Member]	9 Months Ended
	Sep. 30, 2020$ / sharesshares
Shareholders' Equity (Details) - Schedule of RSUs activity [Line Items]
Awarded and unvested at December 31, 2019 | shares	1,733,132
Awarded and unvested at December 31, 2019 | $ / shares	$ 2.09
Granted | shares	1,359,000
Granted | $ / shares	$ 1.28
Vested | shares	(856,132)
Vested | $ / shares	$ 2.30
Forfeited | shares	(42,500)
Forfeited | $ / shares	$ 2.30
Awarded and unvested at September 30, 2020 | shares	2,193,500
Awarded and unvested at September 30, 2020 | $ / shares	$ 1.50

Shareholders' Equity (Details_5

Shareholders' Equity (Details) - Schedule of stock-based compensation expense - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Shareholders' Equity (Details) - Schedule of stock-based compensation expense [Line Items]
Compensation expense	$ 724	$ 419	$ 1,876	$ 1,002
Cost of revenues [Member]
Shareholders' Equity (Details) - Schedule of stock-based compensation expense [Line Items]
Compensation expense	21	36	85	98
Research and development [Member]
Shareholders' Equity (Details) - Schedule of stock-based compensation expense [Line Items]
Compensation expense	70	78	229	203
Sales and marketing [Member]
Shareholders' Equity (Details) - Schedule of stock-based compensation expense [Line Items]
Compensation expense	65	51	204	148
General and administrative [Member]
Shareholders' Equity (Details) - Schedule of stock-based compensation expense [Line Items]
Compensation expense	$ 568	$ 254	$ 1,358	$ 553

Segment and Geographic Inform_3

Segment and Geographic Information (Details) $ in Thousands	9 Months Ended
	Sep. 30, 2020USD ($)	Sep. 30, 2019
Segment Reporting [Abstract]
Number of reportable segments	1
Revenues derived from customer A	22.00%	20.00%
Segment reporting, major customer's description	For the quarter ended September 30, 2020, no other customer accounted for more than 10% of total revenue.
Revenue remaining performance obligation	$ 40,695
Description of revenue remaining performance obligation	The Company expects to recognize revenue on approximately 22% of these remaining performance obligations during the remainder of 2020, approximately 53% in 2021, with the remainder recognized thereafter.
Additional agreements, description	we signed two additional agreements that will increase revenues from this customer during the fourth quarter of 2020 and the first quarter of 2021. We also received notification that this customer will renew one of their contracts for another three years through the first quarter of 2024, but that it does not intend to renew its largest contract with the Company at full value beginning in April 2021. As a result, we anticipate that quarterly revenues from this customer will drop from over 20% currently to approximately 12% of quarterly revenue beginning in the second quarter of 2021.

Segment and Geographic Inform_4

Segment and Geographic Information (Details) - Schedule of total revenue by geographic area - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Segment and Geographic Information (Details) - Schedule of total revenue by geographic area [Line Items]
Revenues from external customers	$ 9,114	$ 9,496	$ 27,944	$ 28,862
United States [Member]
Segment and Geographic Information (Details) - Schedule of total revenue by geographic area [Line Items]
Revenues from external customers	4,201	4,470	13,075	13,552
Germany [Member]
Segment and Geographic Information (Details) - Schedule of total revenue by geographic area [Line Items]
Revenues from external customers	2,109	2,153	6,269	6,617
Europe [Member]
Segment and Geographic Information (Details) - Schedule of total revenue by geographic area [Line Items]
Revenues from external customers	966	890	2,993	2,573
Asia Pacific [Member]
Segment and Geographic Information (Details) - Schedule of total revenue by geographic area [Line Items]
Revenues from external customers	667	661	1,900	1,930
Israel [Member]
Segment and Geographic Information (Details) - Schedule of total revenue by geographic area [Line Items]
Revenues from external customers	1,001	1,251	3,350	3,971
Other [Member]
Segment and Geographic Information (Details) - Schedule of total revenue by geographic area [Line Items]
Revenues from external customers	$ 170	$ 71	$ 357	$ 219

Segment and Geographic Inform_5

Segment and Geographic Information (Details) - Schedule of revenue generated by Customer Type - USD ($) $ in Thousands		3 Months Ended		9 Months Ended
		Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Revenue from External Customer [Line Items]
Revenues from external customers		$ 9,114	$ 9,496	$ 27,944	$ 28,862
OEM/Embedded Security [Member]
Revenue from External Customer [Line Items]
Revenues from external customers	[1]	7,354	7,691	22,771	23,363
Enterprise/SMB [Member]
Revenue from External Customer [Line Items]
Revenues from external customers	[2]	$ 1,760	$ 1,805	$ 5,173	$ 5,499
[1]	This market represents customers who embed Cyren Threat Detection Services and Threat Intelligence Feeds into their infrastructure and/or products to protect their customers and users.
[2]	In this market, Cyren provides enterprise customers email security products, threat intelligence and cloud-based sandbox threat analysis to protect their employees, data and IP.

Segment and Geographic Inform_6

Segment and Geographic Information (Details) - Schedule of net amount of property and equipment - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019
Segment and Geographic Information (Details) - Schedule of net amount of property and equipment [Line Items]
Net amount of property and equipment	$ 4,410	$ 4,410
Israel [Member]
Segment and Geographic Information (Details) - Schedule of net amount of property and equipment [Line Items]
Net amount of property and equipment	1,063	1,291
United States [Member]
Segment and Geographic Information (Details) - Schedule of net amount of property and equipment [Line Items]
Net amount of property and equipment	1,439	1,527
Germany [Member]
Segment and Geographic Information (Details) - Schedule of net amount of property and equipment [Line Items]
Net amount of property and equipment	1,735	1,345
Other [Member]
Segment and Geographic Information (Details) - Schedule of net amount of property and equipment [Line Items]
Net amount of property and equipment	$ 173	$ 247

Financial Expense, Net (Details

Financial Expense, Net (Details) - Schedule of financial expense, net - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Income:
Interest on cash and cash equivalents		$ 1		$ 22
Expenses:
Interest expense, net of interest capitalized	(410)	(92)	(902)	(307)
Foreign currency exchange differences, net	189	(218)	196	(311)
Other	(15)	(12)	(51)	(46)
Financial income (expenses), net	$ (236)	$ (321)	$ (757)	$ (642)

Related Parties (Details) - Sch

Related Parties (Details) - Schedule of balances with related parties - USD ($) $ in Thousands		Sep. 30, 2020	Dec. 31, 2019
Schedule of balances with related parties [Abstract]
Interest expense accrual – Convertible Notes	[1]	$ 181	$ 32
Long term Convertible Notes	[2]	10,000	10,000
Long term Convertible Debentures	[3]	$ 233
[1]	Related to the semi-annual interest payments due in June and December related to the Convertible Notes entered into December 5, 2018. See note 5b. for further details.
[2]	Related to the Convertible Notes entered into December 5, 2018. See note 5b. for further details.
[3]	Related to the Convertible Debentures entered into March 19, 2020 See note 5c. for further details.

Related Parties (Details) - S_2

Related Parties (Details) - Schedule of transactions with related parties - USD ($) $ in Thousands		3 Months Ended		9 Months Ended
		Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Schedule of transactions with related parties [Abstract]
Interest expense on Convertible Notes	[1]	$ 153	$ 141	$ 436	$ 424
Interest expense on Convertible Debentures	[2]	$ 5		$ 10
[1]	Related to the semi-annual interest payments due in June and December related to the Convertible Notes entered into December 5, 2018. See note 5b. for further details.
[2]	Related to the semi-annual interest payments due in September and March related to the Convertible Debentures entered into March 19, 2020. See note 5c. for further details.